FDA wants to hear from you about how women, minorities, and the elderly are included and evaluated in ClinicalTrials
The Food and Drug Administration (FDA) is announcing a public hearing to obtain input on the issues and challenges associated with the collection, analysis, and availability of demographic subgroup data (i.e. sex, race/ethnicity, and age)in applications for approval of FDA‐regulated medical products.
The Agency will utilize input from this public hearing to develop a plan that is pragmatic and public‐health focused.
There will be an opportunity for attendees to make oral presentations during the meeting. The deadline for registering as a presenter is March 21, 2014. There is also an open public docket for the meeting. Comments will be accepted until May 16, 2014.
|Date||April 1, 2014|
|Time||9:00 a.m. to 4:00 p.m.|
|Location:||FDA White Oak Campus
10903 New Hampshire Ave.
Building 31, Great Room(1503)
Silver Spring, MD 20993
For more information and to register:
Visit the website at: FDA Public Hearing: FDASIA Section 907
(Note: Registration for presenters closes on March 21, 2014)